Friday, May 25, 2012

Not really a surprise: Pom disagrees with my reading of the FTC decision

Apparently its new ad campaign will focus on claims like "supports prostate health," in stated reliance on the ALJ's ruling.  Not clear whether Pom has consumer reaction evidence indicating that consumers do not receive a treatment/prevention message from such claims--like "heart therapy," below.  (Who are you going to trust, the government or the business that makes money when you buy its stuff?)  But I suppose if you're in a hole, there's no reason not to keep digging, and again you can't deny the chutzpah of using the ALJ as a citation for your "benefit" claim.

No comments: